Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.

导出 OA

翻译打印收藏纠错

作者： Junjie,Li ^[1] ; Raymond,Oyen ; Alfons,Verbruggen ; Yicheng,Ni

作者单位： 1. Department of Imaging and Pathology, Biomedical Sciences Group; KU Leuven, Belgium. ; 2. Molecular Small Animal Imaging Center, Faculty of Medicine; KU Leuven, Belgium. ^[1]

关键词 SMSDTTS combretastatin A4 phosphate hypericin.necrosis avid contrast agent small molecule sequential dual-targeting theragnostic strategy vascular disrupting agent

DOI 10.7150/jca.5635

PMID 23412554

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览68

Journal of Cancer

2013年4卷2期

133-45页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.

Journal of Cancer

相似文献

Journal of Cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.

Journal of Cancer

相似文献

Journal of Cancer

相关期刊

检索历史清除